Involvement of potential pathways in malignant transformation from Oral Leukoplakia to Oral Squamous Cell Carcinoma revealed by proteomic analysis

BackgroundOral squamous cell carcinoma (OSCC) is one of the most common forms of cancer associated with the presence of precancerous oral leukoplakia. Given the poor prognosis associated with oral leukoplakia, and the difficulties in distinguishing it from cancer lesions, there is an urgent need to elucidate the molecular determinants and critical signal pathways underlying the malignant transformation of precancerous to cancerous tissue, and thus to identify novel diagnostic and therapeutic target.ResultsWe have utilized two dimensional electrophoresis (2-DE) followed by ESI-Q-TOF-LC-MS/MS to identify proteins differentially expressed in six pairs of oral leukoplakia tissues with dysplasia and oral squamous cancer tissues, each pair was collected from a single patient. Approximately 85 differentially and constantly expressed proteins (> two-fold change, P < 0.05) were identified, including 52 up-regulated and 33 down-regulated. Gene ontological methods were employed to identify the biological processes that were over-represented in this carcinogenic stage. Biological networks were also constructed to reveal the potential links between those protein candidates. Among them, three homologs of proteosome activator PA28 a, b and g were shown to have up-regulated mRNA levels in OSCC cells relative to oral keratinocytes.ConclusionVarying levels of differentially expressed proteins were possibly involved in the malignant transformation of oral leukoplakia. Their expression levels, bioprocess, and interaction networks were analyzed using a bioinformatics approach. This study shows that the three homologs of PA28 may play an important role in malignant transformation and is an example of a systematic biology study, in which functional proteomics were constructed to help to elucidate mechanistic aspects and potential involvement of proteins. Our results provide new insights into the pathogenesis of oral cancer. These differentially expressed proteins may have utility as useful candidate markers of OSCC.

[1]  Qianming Chen,et al.  Comparative Proteomics Approach to Screening of Potential Diagnostic and Therapeutic Targets for Oral Squamous Cell Carcinoma*S , 2008, Molecular & Cellular Proteomics.

[2]  F. Tsai,et al.  S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. , 2007, Journal of proteome research.

[3]  Y. Nishizuka,et al.  Loss in transformed cells of cell cycle regulation of expression of a nuclear protein recognized by SLE patient antisera. , 1989, Experimental cell research.

[4]  T. Onda,et al.  Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma. , 2006, International journal of oncology.

[5]  M. Weichenthal,et al.  Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours , 2007, Journal of Cancer Research and Clinical Oncology.

[6]  C. Watts.  The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules , 2004, Nature Immunology.

[7]  M. Kesting,et al.  Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. , 2009, Oral oncology.

[8]  D. Mayer,et al.  S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. , 2006, Experimental cell research.

[9]  Yasuhiro Ito,et al.  S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. , 2008, Current cancer drug targets.

[10]  B. Honoré,et al.  Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. , 1996, The Journal of urology.

[11]  Lance F. Barton,et al.  Immune Defects in 28-kDa Proteasome Activator γ-Deficient Mice1 , 2004, The Journal of Immunology.

[12]  S. Cross,et al.  Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. , 2004, Human pathology.

[13]  R. Cramer,et al.  PIGOK: Linking protein identity to gene ontology and function. , 2006, Journal of Proteome Research.

[14]  P. Speight,et al.  Oral epithelial dysplasia: clinical characteristics of western European residents. , 2003, Oral oncology.

[15]  Qing‐Yu He,et al.  Identification of tumor‐associated proteins in oral tongue squamous cell carcinoma by proteomics , 2004, Proteomics.

[16]  Joanna S Morris,et al.  Annexin A8 Is Up-Regulated During Mouse Mammary Gland Involution and Predicts Poor Survival in Breast Cancer , 2005, Clinical Cancer Research.

[17]  J. Carlis,et al.  Proteomics Analysis of Cells in Whole Saliva from Oral Cancer Patients via Value-added Three-dimensional Peptide Fractionation and Tandem Mass Spectrometry*S , 2008, Molecular & Cellular Proteomics.

[18]  H. Leffers,et al.  Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. , 1992, The Journal of investigative dermatology.

[19]  J. Yewdell,et al.  Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.

[20]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[21]  P. Watson,et al.  Reciprocal negative regulation between S100A7/psoriasin and β-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity , 2008, Oncogene.

[22]  S. Cross,et al.  Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers , 2005, Histopathology.

[23]  L. Kornberg,et al.  Gene Expression Profiling in Squamous Cell Carcinoma of the Oral Cavity Shows Abnormalities in Several Signaling Pathways , 2005, The Laryngoscope.

[24]  C. Scharf,et al.  Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. , 2004, Cancer letters.

[25]  S. Lippman,et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  J. Rodrigo,et al.  Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. , 2004, The American journal of pathology.

[27]  C. Hill,et al.  The 11S regulators of 20S proteasome activity. , 2002, Current topics in microbiology and immunology.

[28]  R. Hruban,et al.  New Markers of Pancreatic Cancer Identified Through Differential Gene Expression Analyses: Claudin 18 and Annexin A8 , 2008, The American journal of surgical pathology.

[29]  L. Murphy,et al.  Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  K. Uzawa,et al.  Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. , 2005, International journal of oncology.

[31]  F. Watzinger,et al.  Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. , 2008, Journal of proteome research.

[32]  David Elashoff,et al.  Salivary Proteomics for Oral Cancer Biomarker Discovery , 2008, Clinical Cancer Research.

[33]  Jiří Knížek,et al.  Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma , 1999, Electrophoresis.

[34]  C. Heizmann,et al.  S100A16, a Novel Calcium-binding Protein of the EF-hand Superfamily* , 2006, Journal of Biological Chemistry.

[35]  M. Hier,et al.  Clinically relevant oral cancer model for serum proteomic eavesdropping on the tumour microenvironment. , 2006, The Journal of otolaryngology.

[36]  A. Ciechanover,et al.  Ubiquitin‐mediated proteolysis: biological regulation via destruction , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[37]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[38]  D. Saranath,et al.  Contemporary issues in oral cancer , 2000 .

[39]  G. Murray,et al.  Characterisation and protein expression profiling of annexins in colorectal cancer , 2007, British Journal of Cancer.

[40]  C. Reutelingsperger,et al.  Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance. , 2006, Cancer research.

[41]  K. Harada,et al.  A proteomics approach to characterizing human submandibular gland cell lines by fluorescent two-dimensional differential in-gel electrophoresis. , 2006, International journal of molecular medicine.